Hervolution Therapeutics: Funding, Investors & Team (Sep 2026)
Hervolution Therapeutics focuses on developing first-in-class immunotherapies to combat tumors from within. The company leverages Human Endogenous Retroviral proteins (HERVs) to create rationally designed immune therapeutics targeting the dark genome. Hervolution Therapeutics aims to address hidden enemies within the human body by pioneering innovative biotechnology solutions.
Hervolution Therapeutics has raised $11.7M across 1 funding round on record, the most recent a Series A of $11.7M announced in Dec 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Hervolution Therapeutics Company Profile and Key Stats
Latest funding round on record: Dec 2024.
Hervolution Therapeutics Funding Rounds
Hervolution Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Hervolution Therapeutics Funding Compared to Other Biotechnology Startups
Hervolution Therapeutics' latest round of $11.7M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Hervolution Therapeutics in Biotechnology and Copenhagen
Companies Similar to Hervolution Therapeutics
Curasight is a biotech company focused on addressing the need for improved diagnosis and treatment of several…
Alcolase is a Danish life science start-up that specializes in alcohol flushing.
ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on…
ENZIDIA is unleashing the biomanufacturing revolution with an enzyme acceleration revolution
Gefjon Pharma is a biopharmaceutical company focused on developing innovative solutions to combat…
Synuca Therapeutics focused on developing innovative therapies for neurological disorders, particularly…
Galecto develops small molecules for the treatment of severe diseases, including fibrosis and cancer. The…
Pioneering new sustainable bio-based ingredients
Muna Therapeutics is a private biopharmaceutical company that discovers and develops therapies that slow or…
EvodiaBio is a company in the bio-industrial sector that develops eco-friendly fragrances for the food and…
Fida Biosystems is a technology that provides the detection and characterization of proteins and…
Chromologics is a company that creates new and original food colorings utilizing natural ingredients. Derived…
Hervolution Therapeutics Funding FAQs
What does Hervolution Therapeutics do?
Hervolution Therapeutics focuses on developing first-in-class immunotherapies to combat tumors from within. The company leverages Human Endogenous Retroviral proteins (HERVs) to create rationally designed immune therapeutics targeting the dark genome. Hervolution Therapeutics aims to address hidden enemies within the human body by pioneering innovative biotechnology solutions.
How much funding has Hervolution Therapeutics raised?
Hervolution Therapeutics has raised $11.7M across 1 round on record. The most recent is a Series A of $11.7M announced in Dec 2024.
When did Hervolution Therapeutics last raise funding?
Hervolution Therapeutics' most recent funding round on record is a Series A of $11.7M, announced in Dec 2024.
Who founded Hervolution Therapeutics?
FundedIQ lists Peter Johannes Holst (Founder) at Hervolution Therapeutics.
Where is Hervolution Therapeutics headquartered?
Hervolution Therapeutics is based in Copenhagen, Hovedstaden, Denmark.
How many employees does Hervolution Therapeutics have?
Hervolution Therapeutics is in the 1-10 employee band.
How does Hervolution Therapeutics' funding compare to other Biotechnology startups?
Hervolution Therapeutics' latest round of $11.7M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Hervolution Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Hervolution Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.